DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

0
Player Avatar CiscoKid101 (< 20) Submitted: 1/12/2007 10:48:30 AM : Outperform Start Price: $53.22 DVA Score: +55.04

Here come the baby-boomers!

Featured Broker Partners


Advertisement